CN110866354A - Optimized design method of polymer vascular stent structure considering scale effect - Google Patents

Optimized design method of polymer vascular stent structure considering scale effect Download PDF

Info

Publication number
CN110866354A
CN110866354A CN201911084942.1A CN201911084942A CN110866354A CN 110866354 A CN110866354 A CN 110866354A CN 201911084942 A CN201911084942 A CN 201911084942A CN 110866354 A CN110866354 A CN 110866354A
Authority
CN
China
Prior art keywords
design
stent
function
polymer
point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911084942.1A
Other languages
Chinese (zh)
Other versions
CN110866354B (en
Inventor
李红霞
朱宝
高易仁
王敏杰
赵丹阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN201911084942.1A priority Critical patent/CN110866354B/en
Publication of CN110866354A publication Critical patent/CN110866354A/en
Application granted granted Critical
Publication of CN110866354B publication Critical patent/CN110866354B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Media Introduction/Drainage Providing Device (AREA)

Abstract

The invention relates to a scale effect-considered polymer intravascular stent structure optimization design method, belongs to the field of interventional medical instruments, and relates to a scale effect-considered polymer intravascular stent structure optimization design method. The method comprises the steps of obtaining initial sample points by defining an optimization problem and adopting an optimized Latin hypercube method on the basis of considering the influence of a scale effect on the mechanical behavior of a support, and establishing an approximate function relation between a target function and a design variable by using a Kriging agent model in combination with a finite element method. And based on the approximate function and the criterion of improving the expected point adding, combining the genetic algorithm and the sequence quadratic programming algorithm to carry out parallel operation to obtain the improved design of the bracket structure. And outputting the final optimization design result of the support when the optimal solution of the objective function meets the convergence condition. The invention makes up the defect of neglecting the scale effect in the prior art, introduces the novel constitutive relation into the finite element calculation, adopts the optimization algorithm to improve the calculation precision and the calculation efficiency, and has strong applicability.

Description

Optimized design method of polymer vascular stent structure considering scale effect
Technical Field
The invention belongs to the technical field of interventional medical instruments, and particularly relates to a scale effect considered optimal design method of a polymer vascular stent structure.
Background
At present, cardiovascular and cerebrovascular diseases are the leading killers of death, and the blood flow blockage caused by vascular stenosis is the main reason for triggering the diseases. The polymer intravascular stent is used as an interventional medical appliance implanted into a human body, can effectively avoid angiostenosis, reduce morbidity, and meet a plurality of performance indexes such as radial support rigidity, radial elastic recovery, axial shortening, surface coverage rate and the like simultaneously in order to ensure the safety and reliability of the stent in a long-term service process and meet the structural design requirements. Meanwhile, with the continuous development of polymer fine manufacturing technology, more and more researches show that the polymer material has scale effect under the micro-scale. Unlike conventional continuous medium mechanics, when a material is deformed non-uniformly on a micro-scale, its apparent elastic modulus or hardness is greatly increased. The microporous structure is formed inside the polymer intravascular stent due to material degradation in the service process, and the effect exists when the structure is bent and twisted. On the premise of considering the scale effect, how to establish an effective method and realize the multi-objective optimization design of the polymer vascular stent structure becomes a problem to be solved at present.
The invention patent application number of terminal end et al is 201711292177.3, and discloses a method, a device and electronic equipment for simulating the expansion of a virtual stent in a blood vessel, which realizes the real-time monitoring of the expansion condition of the stent in the blood vessel, but the invention only displays the three-dimensional expansion process of the stent, does not consider the influence of the scale effect on the mechanical property of the stent, and does not make a corresponding structure optimization design method. The invention discloses a manual intervention type aortic valve stent with radial support force change, which is disclosed as 201910181781.1 in the invention patent application number of Yanyogo et al.
The invention patent application number 201910178807.7 of Lihongxia et al discloses a drug sustained release simulation and optimization method for a drug eluting stent, which optimizes parameters of the drug eluting stent by finite element simulation and surrogate model optimization methods, and can shorten the research and development period of the drug eluting stent, but the method does not consider the influence of scale effect and stent structure on the mechanical performance of the stent, and lacks applicability in the aspect of stent structure optimization design.
Disclosure of Invention
Aiming at the defects of the prior art, the influence of the scale effect on the mechanical property of the degradable vascular stent is not considered, the structural design of the vascular stent mostly takes experience adjustment as the main part, and the vascular stent designed in the prior art lacks general applicability in the face of complex implantation environment, so that the invention provides the optimal design method of the polymer vascular stent structure considering the scale effect. The influence of the scale effect and the support structure on the mechanical performance of the support is considered, the calculation accuracy and the calculation efficiency are improved by using the optimization algorithm, and the applicability is strong.
The method adopts the technical scheme that the method is an optimized design method of the polymer vascular stent structure considering the scale effect, obtains initial sample points by defining an optimization problem and adopting an optimized Latin hypercube method on the basis of considering the influence of the scale effect on the stent mechanical behavior, and establishes an approximate functional relation between a target function and a design variable by using a Kriging agent model in combination with a finite element method. And based on the approximate function and the criterion of improving the expected point adding, combining the genetic algorithm and the sequence quadratic programming algorithm to carry out parallel operation to obtain the improved design of the bracket structure. And outputting the final optimization design result of the support when the optimal solution of the objective function meets the convergence condition. The method comprises the following specific steps:
step one, introducing even stress m and curvature strain χ based on a Cosserat continuous medium theory, and establishing a polymer material constitutive relation considering a scale effect:
Figure BDA0002265115210000021
wherein the Cauchy stress sigma, the even stress m, the Cauchy strain epsilon and the curvature strain chi are vector forms:
σ=[σxxσyyσzzτxyτyxτyzτzyτzxτxz]T(2)
m=[mxxmyymzzmxymyxmyzmzymzxmxz]T(3)
ε=[εxxεyyεzzεxyεyxεyzεzyεzxεxz]T(4)
χ=[χxxχyyχzzχxyχyxχyzχzyχzxχxz]T(5)
the generalized elastic stiffness matrix D is:
Figure BDA0002265115210000022
wherein D isuuAnd DωωThe rigidity matrix D is respectively related to the displacement and rotation of any material point in the polymer blood vessel stent material1、D2、D3Is defined as:
Figure BDA0002265115210000031
Figure BDA0002265115210000032
Figure BDA0002265115210000033
wherein, Λ is E v/(1 + v) (1-2 v) and μ are Lame constants, E is elastic modulus, v is Poisson's ratio, μcIs the second shear modulus,/tIs the characteristic length, l, associated with the torsion of the materialbIs a characteristic length associated with material bending;
generalized stress sigmagAnd generalized strain εgThe equivalent of (a) is:
Figure BDA0002265115210000034
by constructing a polymer material somatic cell model with micro-cavities, the equivalent constitutive relation function of the polymer material is obtained as follows
Figure BDA0002265115210000035
Wherein u isiAnd FiIs the displacement and force of the upper boundary of the somatic cell, S is the upper boundary area of the somatic cell, heIs the length of the somatic cell in the i direction, VeIs the somatic volume.
Step two, defining the structure optimization design problem of the polymer degradable vascular stent, wherein the structure optimization design problem comprises design variables, design targets and constraint conditions;
the radial elastic retraction, the axial shortening and the surface coverage rate in the expansion period are minimized under the conditions that the stent has enough supporting force in the supporting period and has enough supporting force retention rate in the blood vessel remodeling period.
Optimally designing the polymer intravascular stent by taking the length a and the width b of the diamond holes as design variables; the mathematical expression of the structure optimization design problem is as follows:
Figure BDA0002265115210000041
wherein, ER, AS and SC are respectively the radial elastic retraction rate, the axial retraction rate and the surface coverage rate of the vascular stent, u is the structural design variable of the polymer vascular stent,
Figure BDA0002265115210000042
andurespectively are the upper limit and the lower limit of the design variable, I is the number of the design variable,
Figure BDA0002265115210000043
is the minimum radial support force, μ, required for a given support period0Is the minimum holding force required for a given period of vascular remodelingAnd (4) rate.
Extracting 16 design variable initial sample points in a design space by adopting an optimized Latin hypercube method;
1) dividing each dimensional interval of the design variable into 16 intervals with equal probability;
2) randomly extracting a point in each interval of each dimension;
3) randomly extracting one point from the points extracted in the step 2) for each dimension, and forming a vector by using the points;
analyzing the sample points extracted in the third step by adopting a three-dimensional finite element model, wherein the finite element model comprises four parts, namely a blood vessel, a thrombus plaque, a polymer blood vessel stent and a balloon, and because the whole model has symmetry, 1/12 of the whole model, namely a circumferential 1/6 and an axial 1/2 are selected for simulation calculation in order to improve the calculation speed; performing grid division on the model by using ANSYS17.0, wherein the blood vessel, the thrombus plaque and the polymer vascular stent adopt 8-node Solid 185 entity units, and the balloon adopts 4-node Shell181 Shell units;
the load and boundary conditions applied to the finite element model are as follows:
1) applying symmetry constraints on the symmetry planes of the polymer vascular stent, the blood vessel and the thrombus plaque, and simultaneously constraining circumferential rotation and axial movement of the balloon;
2) the load is added by applying an internal pressure changing along with time in the saccule, the internal pressure change curve is divided into three parts of linear loading, constant loading and linear unloading, and the blood vessel support changes along with the change of the internal pressure of the saccule.
Solving the target function response value of each initial sample point, and selecting a group of samples corresponding to the minimum response value as an optimization starting point;
based on sample information, an approximate functional relation between a target function and a design variable is obtained by using a Kriging agent model, and the agent model comprises a regression part and a nonparametric part
Figure BDA0002265115210000044
Where β is the regression coefficient, f (x) is the regression polynomial determined by training the samples, and the global approximation is simulated in the design space, and z (x) is the random distribution error, which provides an approximation simulation of the local bias, with the statistical properties:
E[z(x)]=0 (14)
Figure BDA0002265115210000051
Figure BDA0002265115210000052
wherein x isiAnd xjIs any two sample points, R (θ, x)i,xj) Theta is a parameter for representing the spatial correlation of each sample point, and the correlation function R is expressed by a continuous differentiable Gaussian function
Figure BDA0002265115210000053
In the formula, nvIs the number of known design variables and,
Figure BDA0002265115210000054
and
Figure BDA0002265115210000055
respectively, known sample point xiAnd xjThe kth component of (a);
from a known set of sample points
Figure BDA0002265115210000056
And a set of responses
Figure BDA0002265115210000057
For any newly added sample point xnewThe response value can be predicted from a linear combination of the response set Y of known sample points:
Figure BDA0002265115210000058
the estimation error is:
Figure BDA0002265115210000059
wherein F ═ F1,f2,…fn]T,Z=[z1,z2,…zn]T. At the same time, the average of the prediction errors must be equal to zero, i.e. the average of the prediction errors must be equal to zero, since the unbiased requirement needs to be met
Figure BDA00022651152100000510
Then there are:
FTc-f=0 (21)
the estimated variance is:
Figure BDA00022651152100000511
after finishing, the method comprises the following steps:
Figure BDA0002265115210000061
wherein the content of the first and second substances,
Figure BDA0002265115210000062
this equation characterizes the new sample point xnewCorrelation in space with other known sample points. Then, a coefficient c is obtained by minimizing the estimation variance of the estimation value, and the optimization model is as follows:
Figure BDA0002265115210000063
and (3) solving by using a Lagrange multiplier method:
c=R-1[r-F(FTR-1F)-1(FTR-1r-f)](26)
the estimated variance of the estimated value is obtained as follows:
Figure BDA0002265115210000064
get the new sample point xnewEstimated value of (a):
Figure BDA0002265115210000065
using regression problems
Figure BDA0002265115210000066
The generalized least squares estimate of (a) can be obtained:
β*=(FTR-1F)-1FTR-1Y (29)
margin expression R gamma considering the regression problem*=Y-Fβ*It is possible to obtain:
Figure BDA0002265115210000067
the matrix F, R and vector Y are derived from a set S of known sample points, for a new sample point xnewIf f (x) can be obtainednew) And r (x)new) Then, a new sample point x can be obtainednewThe estimated response value of (2), only the unknown parameters need to be solved at this time
Figure BDA0002265115210000068
And the parameter θ in R, the likelihood function of y (x) being, due to obeying a normal distribution:
Figure BDA0002265115210000069
taking the logarithm of the above equation and removing the constant term yields:
Figure BDA0002265115210000071
relate to
Figure BDA0002265115210000072
The standing value of (c) can be obtained:
Figure BDA0002265115210000073
further obtaining:
Figure BDA0002265115210000074
the maximum likelihood estimate of theta is obtained by solving the maximum of the log-likelihood function, i.e.
Figure BDA0002265115210000075
And finally, obtaining an approximate functional relation between the target function and the design variable.
Step six, solving the expected EI improvement corresponding to the objective function F (x)
E[I(x)]=σ(x)[uΦ(u)+φ(u)](36)
Figure BDA0002265115210000076
Wherein the content of the first and second substances,
Figure BDA0002265115210000077
and σ2(x) Is the mean and mean square error, Y, corresponding to any design point x in spaceminIs the current optimum value, phi is the regularization probability distribution function, phi is the probability density function;
based on the approximate function and the improved expected EI, the genetic algorithm and the sequence quadratic programming algorithm are utilized to carry out the combined operation to obtain the improved design result of the bracket,
1) based on EI value, obtaining optimal solution x by adopting genetic algorithm and sequence quadratic programming algorithmk1 *And xk2 *
2) Based on approximate function, obtaining optimal solution x by adopting genetic algorithm and sequence quadratic programming algorithmk3 *And xk4 *
Step seven, respectively solving x by using Kriging agent modelk1 *、xk2 *、xk3 *And xk4 *Predicted value of (2)
Figure BDA0002265115210000078
And
Figure BDA0002265115210000079
separately computing x by finite element methodk1 *、xk2 *、xk3 *And xk4 *Is the objective function value F (x)k1 *)、F(xk2 *)、F(xk3 *) And F (x)k4 *) And selecting the better one as the current optimal solution F (x)k *)。
Step eight, checking convergence conditions as follows:
1)
Figure BDA0002265115210000081
2)
Figure BDA0002265115210000082
3)|F(xk *)-F(xk-1 *)|≤ε2(40)
wherein, Deltar、ε1And ε2Is given convergence accuracy, YmaxAnd YminIs the maximum and minimum response value in the sample points, and k is the number of iteration steps of the optimization procedure.
1) When the objective function is optimal, the solution F (x)k *) When the convergence condition is not satisfied, adding an improved design point xk1 *、xk2 *、xk3 *And xk4 *Continuing to iteratively solve in the sample until the sample is satisfiedA convergence condition;
2) when the objective function is optimal, the solution F (x)k *) Outputting the optimized design result x of the polymer vascular stent structure when the convergence condition is metk *
The invention has the advantages that the design method establishes a novel constitutive relation considering the polymer material dimension effect, and introduces the novel constitutive relation into finite element calculation to form a novel calculation method for detecting the mechanical property of the intravascular stent. Aiming at the optimization design of the high nonlinear and multidimensional large-scale design space of the balloon-expandable intravascular stent, the approximate function relation between the objective function and the design variable is constructed by using a Kriging surrogate model, and the calculation efficiency is obviously improved. The genetic algorithm and the sequence quadratic programming algorithm are combined, the advantages of high local optimization efficiency and strong global optimization capability of the genetic algorithm and the sequence quadratic programming algorithm are fully exerted, and the optimization process is enabled to efficiently approach the global optimal solution. The invention makes up the defect of neglecting the scale effect in the prior art, improves the calculation precision and the calculation efficiency by adopting an optimization algorithm, and has strong applicability.
Drawings
FIG. 1 is a flow chart of a method for optimally designing a polymer vascular stent structure by considering a scale effect.
Fig. 2 shows the process of the degradation rate and the support performance of the polymer blood vessel stent.
Fig. 3 is a geometry of a polymeric vascular stent. Wherein, a is the prismatic length of the polymer vascular stent, b is the prismatic width of the polymer vascular stent, w is the rib width of the polymer vascular stent, and d is the thickness of the polymer vascular stent.
FIG. 4 is a finite element model of a polymer vascular stent in-service process.
Fig. 5 is a time-dependent change in balloon pressure.
Fig. 6 is a cloud of radial displacement profiles of the optimized and original stents.
Detailed Description
The following detailed description of the embodiments of the invention is provided in connection with the accompanying drawings and the accompanying claims.
FIG. 1 is a flow chart of a method for optimally designing a polymer vascular stent structure by considering a scale effect. The design method comprises the following specific steps:
step one, based on a Cosserat continuous medium theory, introducing even stress m and curvature strain chi, and establishing a polymer material constitutive relation considering a scale effect through a formula (1), wherein Cauchy stress sigma, even stress m, Cauchy strain epsilon and curvature strain chi are vector forms and are respectively represented by formulas (2) to (5), a generalized elastic stiffness matrix D is represented by a formula (6), and a stiffness matrix D is specifically represented by formulas (7) to (9)1、D2、D3To express, and then to obtain generalized stress σgAnd generalized strain εgThe equivalent of (c):
Figure BDA0002265115210000091
then passing through a generalized elastic rigidity matrix D and a rigidity matrix D1、D2、D3Equations (9) - (12) establish the elastic constitutive relation equation (11) of the polymer material considering the scale effect.
And step two, defining the structure optimization design problem of the polymer degradable vascular stent, wherein the structure optimization design problem comprises design variables, design targets and constraint conditions.
The polymer vascular stent shown in figure 3 is optimally designed by taking the length a and the width b of the diamond holes as design variables. It can be described specifically as: the radial elastic retraction, the axial shortening and the surface coverage rate in the expansion period are minimized under the conditions that the stent has enough supporting force in the supporting period and has enough supporting force retention rate in the blood vessel remodeling period.
The mathematical expression of the structure optimization design problem is as follows:
Figure BDA0002265115210000092
extracting 16 design variable initial sample points in a design space by adopting an optimized Latin hypercube method, which specifically comprises the following steps:
1) dividing each dimensional interval of the design variable into 16 intervals with equal probability;
2) randomly extracting a point in each interval of each dimension;
3) and randomly extracting one point from the points extracted in the step 2) for each dimension, and forming the points into a vector.
And step four, analyzing the sample points extracted in the step three by using the three-dimensional finite element model shown in the figure 4, wherein the finite element model comprises four parts, namely a blood vessel, a thrombus plaque, a polymer blood vessel stent and a balloon, and because the whole model has symmetry, 1/12 of the whole model, namely the circumferential 1/6 and the axial 1/2 are selected for simulation calculation in order to improve the calculation speed.
The structural parameters of the model are: the length of the blood vessel is 8.4mm, and the thickness is 0.1 mm; the length of the thrombus plaque is 7mm, and the thickness of the proximal end is 0.3 mm; the length of the polymer intravascular stent is 6.875mm, the thickness d is 0.15mm, and the tendon width w is 0.15 mm; the balloon length was 7.6mm and the thickness was 0.05 mm.
And carrying out meshing on the model by using ANSYS17.0, wherein the blood vessel, the thrombus plaque and the polymer blood vessel stent adopt 8-node Solid 185 Solid units, and the balloon adopts 4-node Shell181 Shell units.
The material properties of the model are shown in table 1.
Material Properties of the model of Table 1
Figure BDA0002265115210000101
Fig. 2 shows the process of the degradation rate and the support performance of the polymer blood vessel stent.
Step five, simulating the service process of the polymer intravascular stent, and applying loads and boundary conditions to the finite element model:
1) applying symmetry constraints on the symmetry planes of the polymer vascular stent, the blood vessel and the thrombus plaque, and simultaneously constraining circumferential rotation and axial movement of the balloon;
2) the load is added by applying the internal pressure shown in fig. 5 to the balloon interior, and the internal pressure change curve is divided into three portions of linear loading, constant loading P0.9148 MPa, and linear unloading.
The objective function response value of each initial sample point was solved using ANSYS17.0, and the specific results are shown in table 2.
TABLE 2 results of finite element calculations for initial sample points
Figure BDA0002265115210000102
Figure BDA0002265115210000111
And step six, selecting a group of samples corresponding to the minimum response value as an optimization starting point. Based on the sample information, an approximate functional relationship between the objective function and the design variable shown in formula (13) is obtained by using a Kriging agent model, and the detailed derivation process is shown in formulas (14) - (35).
Seventhly, solving an improved expected EI value corresponding to the objective function F (x) by using formulas (36) and (37), and performing combined operation by using a genetic algorithm and a sequence quadratic programming algorithm to obtain an improved design result of the stent based on an approximate function and the improved expected EI, wherein the improved design result specifically comprises the following steps of:
1) based on EI value, obtaining optimal solution x by adopting genetic algorithm and sequence quadratic programming algorithmk1 *And xk2 *
2) Based on approximate function, obtaining optimal solution x by adopting genetic algorithm and sequence quadratic programming algorithmk3 *、xk4 *
Step eight, respectively solving x by using Kriging agent modelk1 *、xk2 *、xk3 *And xk4 *Predicted value of (2)
Figure BDA0002265115210000112
And
Figure BDA0002265115210000113
separately computing x by finite element methodk1 *、xk2 *、xk3 *And xk4 *Is the objective function value F (x)k1 *)、F(xk2 *)、F(xk3 *) And F (x)k4 *) And selecting the better one as the current optimal solution F (x)k *)。
The convergence conditions shown by equations (38) to (40) are examined:
1) when the objective function is optimal, the solution F (x)k *) When the convergence condition is not satisfied, adding an improved design point xk1 *、xk2 *、xk3 *And xk4 *Continuing iterative solution in the sample until a convergence condition is met;
2) when the objective function is optimal, the solution F (x)k *) Outputting the optimized design result x of the polymer vascular stent structure when the convergence condition is metk *
Finally, the optimal design results are obtained after 21 iterations, as shown in table 3.
TABLE 3 Performance comparison of optimized scaffolds to original and reference scaffolds
Figure BDA0002265115210000114
Figure BDA0002265115210000121
Wherein, the reference bracket only reduces the width w and the thickness d of the rib by 0.02mm on the basis of the original bracket, and other parameters are unchanged.
Compared with the original stent, the radial elastic retraction rate of the optimized stent is almost the same as that of the original stent, which shows that the optimized stent has the radial support capability similar to that of the original stent even if the rib width w of the optimized stent is reduced by 13.33% and the thickness d is reduced by 11.76%. The width w and the thickness d of the rib of the optimized stent are smaller, and the surface coverage rate of the rib is 16.05 percent smaller than that of the original stent, so that the neointimal hyperplasia probability is reduced, the risk of restenosis in the stent is reduced, and meanwhile, the flexibility of the optimized stent is better than that of the original designed stent, and the transportation of the stent in a blood vessel is facilitated. For the axial shortening rate of the stent, the axial shortening rate of the three stents is below 20%, and the constraint condition defined by the optimization problem is met.
In general, the optimized bracket has radial supporting capacity similar to that of the originally designed bracket on the premise of obviously reducing the width w and the thickness d of the rib, the surface coverage rate of the bracket is reduced, and the flexibility of the bracket is improved, so that the comprehensive service performance of the bracket is improved.
Furthermore, compared to the reference stent with simply reduced width w and thickness d of the stent rib, the radial elastic retraction rate of the optimized stent is 22.48% less than that of the reference stent although the optimized stent has the same width and thickness, which indicates that the optimized stent has better radial supporting capability; and the surface coverage of the optimized stent is also slightly less than that of the reference stent, indicating that the likelihood of a long term in-stent restenosis risk for the optimized stent is less.
Fig. 6 depicts a cloud of radial displacement profiles of an optimized stent versus a reference stent after balloon unloading. As can be seen, the radial displacement of the optimized stent as a whole is greater than the radial displacement of the reference stent after balloon unloading. This is because, when the balloon is removed, the stent will undergo radial recoil under the action of the elastic deformation of the vessel and the stent itself, while the radial elastic recoil of the optimized stent is smaller than that of the reference stent, so that the radial displacement on the optimized stent is greater at the last moment than that of the reference stent, which also proves that the optimized stent has better expansion performance and supporting capability.

Claims (1)

1. A polymer blood vessel support structure optimization design method considering scale effect, on the basis of considering the influence of scale effect on support mechanical behavior, by defining optimization problem, obtaining initial sample point by adopting optimized Latin hypercube method, combining finite element method, and establishing approximate function relation between objective function and design variable by using Kriging agent model; based on an approximate function and an improved expected point adding criterion, combining a genetic algorithm and a sequence quadratic programming algorithm to carry out parallel operation to obtain an improved design of the support structure; outputting a final optimization design result of the support when the optimal solution of the objective function meets the convergence condition; the method comprises the following specific steps:
step one, introducing even stress m and curvature strain χ based on a Cosserat continuous medium theory, and establishing a polymer material constitutive relation considering a scale effect:
Figure FDA0002265115200000011
wherein the Cauchy stress sigma, the even stress m, the Cauchy strain epsilon and the curvature strain chi are vector forms:
σ=[σxxσyyσzzτxyτyxτyzτzyτzxτxz]T(2)
m=[mxxmyymzzmxymyxmyzmzymzxmxz]T(3)
ε=[εxxεyyεzzεxyεyxεyzεzyεzxεxz]T(4)
χ=[χxxχyyχzzχxyχyxχyzχzyχzxχxz]T(5)
the generalized elastic stiffness matrix D is:
Figure FDA0002265115200000012
wherein D isuuAnd DωωThe rigidity matrix D is respectively related to the displacement and rotation of any material point in the polymer blood vessel stent material1、D2、D3Is defined as:
Figure FDA0002265115200000013
Figure FDA0002265115200000014
Figure FDA0002265115200000015
wherein, Λ is E v/(1 + v) (1-2 v) and μ are Lame constants, E is elastic modulus, v is Poisson's ratio, μcIs the second shear modulus,/tIs the characteristic length, l, associated with the torsion of the materialbIs a characteristic length associated with material bending;
generalized stress sigmagAnd generalized strain εgThe equivalent of (a) is:
Figure FDA0002265115200000021
by constructing a polymer material somatic cell model with micro-cavities, the equivalent constitutive relation function of the polymer material is obtained as follows:
Figure FDA0002265115200000022
wherein u isiAnd FiIs the displacement and force of the upper boundary of the somatic cell, S is the upper boundary area of the somatic cell, heIs the length of the somatic cell in the i direction, VeIs the somatic volume;
step two, defining the structure optimization design problem of the polymer degradable vascular stent, wherein the structure optimization design problem comprises design variables, design targets and constraint conditions;
the radial elastic retraction, the axial shortening and the surface coverage rate in the expansion period are minimized under the conditions that the stent has enough supporting force in the supporting period and has enough supporting force retention rate in the blood vessel remodeling period;
optimally designing the polymer intravascular stent by taking the length a and the width b of the diamond holes as design variables; the mathematical expression of the structure optimization design problem is as follows:
Figure FDA0002265115200000023
wherein ER, AS and SC are vascular stents respectivelyThe radial elastic retraction rate, the axial shortening rate and the surface coverage rate of the polymer vascular stent, u is a design variable of the polymer vascular stent structure,
Figure FDA0002265115200000024
andurespectively are the upper limit and the lower limit of the design variable, I is the number of the design variable,
Figure FDA0002265115200000025
is the minimum radial support force, μ, required for a given support period0Is the minimum holding force required for a given period of vascular remodeling;
extracting 16 design variable initial sample points in a design space by adopting an optimized Latin hypercube method;
1) dividing each dimensional interval of the design variable into 16 intervals with equal probability;
2) randomly extracting a point in each interval of each dimension;
3) randomly extracting one point from the points extracted in the step 2) for each dimension, and forming a vector by using the points;
analyzing the sample points extracted in the third step by adopting a three-dimensional finite element model, wherein the finite element model comprises four parts, namely a blood vessel, a thrombus plaque, a polymer blood vessel stent and a balloon, and because the whole model has symmetry, 1/12 of the whole model, namely a circumferential 1/6 and an axial 1/2 are selected for simulation calculation in order to improve the calculation speed; performing grid division on the model by using ANSYS17.0, wherein the blood vessel, the thrombus plaque and the polymer vascular stent adopt 8-node Solid 185 entity units, and the balloon adopts 4-node Shell181 Shell units;
the load and boundary conditions applied to the finite element model are as follows:
1) applying symmetry constraints on the symmetry planes of the polymer vascular stent, the blood vessel and the thrombus plaque, and simultaneously constraining circumferential rotation and axial movement of the balloon;
2) the load is added by applying an internal pressure which changes along with time in the saccule, the internal pressure change curve is divided into three parts of linear loading, constant loading and linear unloading, and the vascular stent changes along with the change of the internal pressure of the saccule;
solving the target function response value of each initial sample point, and selecting a group of samples corresponding to the minimum response value as an optimization starting point;
based on sample information, an approximate functional relation between a target function and a design variable is obtained by using a Kriging agent model, and the agent model comprises a regression part and a nonparametric part
Figure FDA0002265115200000031
Wherein β is a regression coefficient, f (x) is a regression polynomial determined by training samples, and approximate simulation is performed on the global in the design space, and z (x) is a random distribution error, and provides approximate simulation of local deviation, and the statistical properties are as follows:
E[z(x)]=0 (14)
Figure FDA0002265115200000032
Figure FDA0002265115200000033
wherein x isiAnd xjIs any two sample points, R (θ, x)i,xj) For the correlation function, θ is a parameter for characterizing the spatial correlation of each sample point, and the correlation function R is expressed as a continuous differentiable gaussian function:
Figure FDA0002265115200000034
in the formula, nvIs the number of known design variables and,
Figure FDA0002265115200000035
and
Figure FDA0002265115200000036
are respectively knownSample point xiAnd xjThe kth component of (a);
from a known set of sample points
Figure FDA0002265115200000037
And a set of responses
Figure FDA0002265115200000038
For any newly added sample point xnewThe response value can be predicted from a linear combination of the response set Y of known sample points:
Figure FDA0002265115200000039
the estimation error is:
Figure FDA0002265115200000041
wherein F ═ F1,f2,…fn]T,Z=[z1,z2,…zn]T(ii) a At the same time, the average of the prediction errors must be equal to zero, i.e. the average of the prediction errors must be equal to zero, since the unbiased requirement needs to be met
Figure FDA0002265115200000042
Then there are:
FTc-f=0 (21)
the estimated variance is:
Figure FDA0002265115200000043
after finishing, the method comprises the following steps:
Figure FDA0002265115200000044
wherein the content of the first and second substances,
Figure FDA0002265115200000045
this equation characterizes the new sample point xnewCorrelation in space with other known sample points; then, a coefficient c is obtained by minimizing the estimation variance of the estimation value, and the optimization model is as follows:
Figure FDA0002265115200000046
and (3) solving by using a Lagrange multiplier method:
c=R-1[r-F(FTR-1F)-1(FTR-1r-f)](26)
the estimated variance of the estimated value is obtained as follows:
Figure FDA0002265115200000047
get the new sample point xnewEstimated value of (a):
Figure FDA0002265115200000048
using regression problems
Figure FDA0002265115200000049
The generalized least squares estimate of (a) can be obtained:
β*=(FTR-1F)-1FTR-1Y (29)
margin expression R gamma considering the regression problem*=Y-Fβ*Obtaining:
Figure FDA0002265115200000051
the matrix F, R and vector Y are derived from a set S of known sample points, for a new sample point xnewIf f (x) can be obtainednew) Andr(xnew) Then, a new sample point x can be obtainednewThe estimated response value of (2), only the unknown parameters need to be solved at this time
Figure FDA0002265115200000052
And the parameter θ in R, the likelihood function of y (x) being, due to obeying a normal distribution:
Figure FDA0002265115200000053
taking the logarithm of the above equation and removing the constant term yields:
Figure FDA0002265115200000054
relate to
Figure FDA0002265115200000055
The standing value of (c) yields:
Figure FDA0002265115200000056
further obtaining:
Figure FDA0002265115200000057
obtaining a maximum likelihood estimate of theta by solving the maximum of the log-likelihood function, i.e.
Figure FDA0002265115200000058
Finally, obtaining an approximate functional relation between the target function and the design variable;
step six, solving the expected EI improvement corresponding to the objective function F (x)
E[I(x)]=σ(x)[uΦ(u)+φ(u)](36)
Figure FDA0002265115200000059
Wherein the content of the first and second substances,
Figure FDA00022651152000000510
and σ2(x) Is the mean and mean square error, Y, corresponding to any design point x in spaceminIs the current optimum value, phi is the regularization probability distribution function, phi is the probability density function;
based on the approximate function and the improved expected EI, the genetic algorithm and the sequence quadratic programming algorithm are utilized to carry out the combined operation to obtain the improved design result of the bracket,
1) based on EI value, obtaining optimal solution x by adopting genetic algorithm and sequence quadratic programming algorithmk1X and xk2*;
2) Based on approximate function, obtaining optimal solution x by adopting genetic algorithm and sequence quadratic programming algorithmk3X and xk4*;
Step seven, respectively solving x by using Kriging agent modelk1*、xk2*、xk3X and xk4Predicted value of
Figure FDA0002265115200000061
Figure FDA0002265115200000062
And
Figure FDA0002265115200000063
separately computing x by finite element methodk1*、xk2*、xk3X and xk4Objective function value of F (x)k1*)、F(xk2*)、F(xk3X) and F (x)k4X) and selecting the better one as the current optimal solution F (x)k*);
Step eight, checking convergence conditions as follows:
1)
Figure FDA0002265115200000064
2)
Figure FDA0002265115200000065
3)|F(xk*)-F(xk-1*)|≤ε2(40)
wherein, Deltar、ε1And ε2Is given convergence accuracy, YmaxAnd YminThe maximum and minimum response values in the sample points, k being the number of iteration steps of the optimization program;
1) when the objective function is optimal, the solution F (x)kX) does not satisfy the convergence condition, add the improved design point xk1*、xk2*、xk3X and xk4Continuing iterative solution in the sample until a convergence condition is met;
2) when the objective function is optimal, the solution F (x)kX) when the convergence condition is satisfied, outputting an optimized design result x of the polymer vascular stent structurek*。
CN201911084942.1A 2019-11-08 2019-11-08 Optimized design method of polymer vascular stent structure considering scale effect Active CN110866354B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911084942.1A CN110866354B (en) 2019-11-08 2019-11-08 Optimized design method of polymer vascular stent structure considering scale effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911084942.1A CN110866354B (en) 2019-11-08 2019-11-08 Optimized design method of polymer vascular stent structure considering scale effect

Publications (2)

Publication Number Publication Date
CN110866354A true CN110866354A (en) 2020-03-06
CN110866354B CN110866354B (en) 2021-08-20

Family

ID=69653328

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911084942.1A Active CN110866354B (en) 2019-11-08 2019-11-08 Optimized design method of polymer vascular stent structure considering scale effect

Country Status (1)

Country Link
CN (1) CN110866354B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113284569A (en) * 2021-04-15 2021-08-20 北京工业大学 Method and device for optimizing plants in orthopedics department, electronic equipment and storage medium
CN113749833A (en) * 2021-09-15 2021-12-07 山西白求恩医院(山西医学科学院) Finite element analysis method of blood vessel stent and blood vessel stent
CN114169192A (en) * 2021-11-23 2022-03-11 北京航空航天大学 Uncertainty analysis method of thermodynamic coupling system based on rough set theory
CN114429536A (en) * 2022-01-04 2022-05-03 华侨大学 Optimization method for porous structure of vascular stent
CN114491976A (en) * 2022-01-04 2022-05-13 华侨大学 Lattice topology optimization structure design method of vascular stent
CN115099077A (en) * 2022-04-25 2022-09-23 华中科技大学 Blood vessel self-folding support structure optimization design method and blood vessel self-folding support structure
CN116993628A (en) * 2023-09-27 2023-11-03 四川大学华西医院 CT image enhancement system for tumor radio frequency ablation guidance

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7124067B2 (en) * 2000-10-17 2006-10-17 Maria-Grazia Ascenzi System and method for modeling bone structure
CN102867083A (en) * 2012-08-30 2013-01-09 浙江大学 High-rigidity and light-weight design method considering uncertainty of slide block mechanism of press machine
CN102967437A (en) * 2012-11-06 2013-03-13 上海交通大学 Testing device for simulating cross self-induced vibration of deep-sea stand columns under inclined uniform flow
US20140025110A1 (en) * 1997-08-01 2014-01-23 Bonutti Skeletal Innovations Llc Apparatus and method for securing a suture
CN105845616A (en) * 2016-06-20 2016-08-10 西安电子科技大学 Manufacturing method for wafer level uniaxial strain GeOI based on silicon nitride stress membrane and scale effect
CN106227993A (en) * 2016-07-14 2016-12-14 哈尔滨理工大学 A kind of union of fracture dynamic process simulation method based on Biological Mechanism
CN107292028A (en) * 2017-06-21 2017-10-24 中国电子产品可靠性与环境试验研究所 It is determined that the method and system of stepped micro- fixed beam structure design
CN107338572A (en) * 2017-05-31 2017-11-10 东华大学 A kind of compound needle of two-dimentional negative poisson's ratio structure textile product shaping and application thereof
CN107978372A (en) * 2017-12-07 2018-05-01 北京理工大学 Analogy method, device and the electronic equipment that virtual bracket is expanded in the blood vessels
CN108153962A (en) * 2017-12-22 2018-06-12 北京工业大学 The first order perturbation expansion asymptotic homogenization of the statistics of random distribution composite material elastic constitutive model Matrix prediction
EP3354715A1 (en) * 2017-01-25 2018-08-01 Industrias Català, S.A. Fabric softening and perfuming composition with anti-lime effect and method for obtaining said composition
CN109637598A (en) * 2019-01-17 2019-04-16 燕山大学 A kind of material mechanical parameters based on bending process determine method
CN109740211A (en) * 2018-12-21 2019-05-10 西北工业大学 A kind of prediction technique of function pipeline fluid structurecoupling inherent characteristic
CN109753764A (en) * 2019-03-11 2019-05-14 大连理工大学 A kind of simulation of bracket for eluting medicament medicament slow release and optimization method
US20190167394A1 (en) * 2017-12-01 2019-06-06 Kulzer Gmbh Tooth cutting guide or tooth ridge lap guide and method of manufacturing the same

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140025110A1 (en) * 1997-08-01 2014-01-23 Bonutti Skeletal Innovations Llc Apparatus and method for securing a suture
US7124067B2 (en) * 2000-10-17 2006-10-17 Maria-Grazia Ascenzi System and method for modeling bone structure
CN102867083A (en) * 2012-08-30 2013-01-09 浙江大学 High-rigidity and light-weight design method considering uncertainty of slide block mechanism of press machine
CN102967437A (en) * 2012-11-06 2013-03-13 上海交通大学 Testing device for simulating cross self-induced vibration of deep-sea stand columns under inclined uniform flow
CN105845616A (en) * 2016-06-20 2016-08-10 西安电子科技大学 Manufacturing method for wafer level uniaxial strain GeOI based on silicon nitride stress membrane and scale effect
CN106227993A (en) * 2016-07-14 2016-12-14 哈尔滨理工大学 A kind of union of fracture dynamic process simulation method based on Biological Mechanism
EP3354715A1 (en) * 2017-01-25 2018-08-01 Industrias Català, S.A. Fabric softening and perfuming composition with anti-lime effect and method for obtaining said composition
CN107338572A (en) * 2017-05-31 2017-11-10 东华大学 A kind of compound needle of two-dimentional negative poisson's ratio structure textile product shaping and application thereof
CN107292028A (en) * 2017-06-21 2017-10-24 中国电子产品可靠性与环境试验研究所 It is determined that the method and system of stepped micro- fixed beam structure design
US20190167394A1 (en) * 2017-12-01 2019-06-06 Kulzer Gmbh Tooth cutting guide or tooth ridge lap guide and method of manufacturing the same
CN107978372A (en) * 2017-12-07 2018-05-01 北京理工大学 Analogy method, device and the electronic equipment that virtual bracket is expanded in the blood vessels
CN108153962A (en) * 2017-12-22 2018-06-12 北京工业大学 The first order perturbation expansion asymptotic homogenization of the statistics of random distribution composite material elastic constitutive model Matrix prediction
CN109740211A (en) * 2018-12-21 2019-05-10 西北工业大学 A kind of prediction technique of function pipeline fluid structurecoupling inherent characteristic
CN109637598A (en) * 2019-01-17 2019-04-16 燕山大学 A kind of material mechanical parameters based on bending process determine method
CN109753764A (en) * 2019-03-11 2019-05-14 大连理工大学 A kind of simulation of bracket for eluting medicament medicament slow release and optimization method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HONGXIA LI等: "《Multi-Objective Optimization of Biodegradable Polymer Stent Structure and Stent Microinjection Molding Process》", 《POLYMERS》 *
W JIANG等: "《Comparison Study on Four Biodegradable Polymer Coatings for Controlling Magnesium Degradation and Human Endothelial Cell Adhesion and Spreading》", 《ACS BIOMATERIALS SCIENCE&ENGINEERING》 *
邵冬冬 等: "《Cosserat理论与模型的研究进展》", 《低温建筑技术》 *
魏云波 等: "《可降解聚合物血管支架体外力学性能测试实验研究》", 《生物医学工程学杂志》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113284569A (en) * 2021-04-15 2021-08-20 北京工业大学 Method and device for optimizing plants in orthopedics department, electronic equipment and storage medium
CN113749833A (en) * 2021-09-15 2021-12-07 山西白求恩医院(山西医学科学院) Finite element analysis method of blood vessel stent and blood vessel stent
CN113749833B (en) * 2021-09-15 2023-12-15 山西白求恩医院(山西医学科学院) Finite element analysis method of vascular stent and vascular stent
CN114169192A (en) * 2021-11-23 2022-03-11 北京航空航天大学 Uncertainty analysis method of thermodynamic coupling system based on rough set theory
CN114429536A (en) * 2022-01-04 2022-05-03 华侨大学 Optimization method for porous structure of vascular stent
CN114491976A (en) * 2022-01-04 2022-05-13 华侨大学 Lattice topology optimization structure design method of vascular stent
CN114491976B (en) * 2022-01-04 2024-06-25 华侨大学 Lattice topology optimization structure design method of vascular stent
CN115099077A (en) * 2022-04-25 2022-09-23 华中科技大学 Blood vessel self-folding support structure optimization design method and blood vessel self-folding support structure
CN115099077B (en) * 2022-04-25 2024-06-25 华中科技大学 Optimized design method of blood vessel self-folding bracket structure and blood vessel self-folding bracket structure
CN116993628A (en) * 2023-09-27 2023-11-03 四川大学华西医院 CT image enhancement system for tumor radio frequency ablation guidance
CN116993628B (en) * 2023-09-27 2023-12-08 四川大学华西医院 CT image enhancement system for tumor radio frequency ablation guidance

Also Published As

Publication number Publication date
CN110866354B (en) 2021-08-20

Similar Documents

Publication Publication Date Title
CN110866354B (en) Optimized design method of polymer vascular stent structure considering scale effect
CN107766628B (en) A kind of dynamic Degradation Reliability appraisal procedure based on life information fusion
An et al. Prognostics 101: A tutorial for particle filter-based prognostics algorithm using Matlab
Hu et al. Reliability-based design optimization under stationary stochastic process loads
Lim et al. A semi-single-loop method using approximation of most probable point for reliability-based design optimization
CN110874502B (en) Aerospace product reliability assessment method based on multi-stage test data reduction
Spranger et al. Comparison and calibration of a real-time virtual stenting algorithm using Finite Element Analysis and Genetic Algorithms
Guiraud et al. A non-central version of the Birnbaum-Saunders distribution for reliability analysis
Putra et al. Multiobjective design optimization of stent geometry with wall deformation for triangular and rectangular struts
Li et al. Multi-objective optimization of coronary stent using Kriging surrogate model
Júnior et al. Probabilistic S–N curves using exponential and power laws equations
Zhu et al. Probabilistic fatigue assessment of notched components under size effect using generalized weakest-link model
Shen et al. Multi-objective optimization design of balloon-expandable coronary stent
Zhuang et al. Remaining useful life prediction of a mechanism considering wear correlation of multiple joints
CN109446731A (en) A kind of Geotechnical Engineering method based on ABAQUS
CN110532620A (en) A kind of Fatigue Crack Propagation Prediction method based on the smooth particle filter of recursive least-squares-core
Qvale et al. A simplified method for weakest-link fatigue assessment based on finite element analysis
Lavrenčič et al. Multiple wrinkling mode transitions in axially compressed cylindrical shell-substrate in dynamics
CN113568067B (en) Numerical weather forecasting method and device, computer storage medium and electronic equipment
CN110991112A (en) Random defect mode superposition method based on response surface method
Wang et al. Multi-objective optimization of bioresorbable magnesium alloy stent by kriging surrogate model
CN112949212A (en) Pressure sensor temperature compensation method and computer readable storage medium
Safikhani et al. The strain gradient approach for determination of forming limit stress and strain diagrams
CN112926147B (en) Posterior optimization design method for reinforced column shell containing defects
CN110852605B (en) Product design decision determining method and system based on information efficiency

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant